VIPpharma ApS: Financial statements 2017
CVR: 38744763
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
VIPpharma ApS (CVR 38744763) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 1,240,080 and a net result of DKK 760. Equity in the 2017 report amounted to DKK 3,188,242. The solvency ratio was 85.6%.
- Gross Profit
- DKK 1,240,080
- Profit/Loss
- DKK 760
- Equity
- DKK 3,188,242
- Total Assets
- DKK 3,726,152
Official annual report
Keep an eye on VIPpharma ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of June 24, 2017, Vibeke Wærens is registered as director of VIPpharma ApS.
VIPpharma ApS was founded on June 24, 2017.
About VIPpharma ApS
VIPpharma ApS is a Danish company of the type Anpartsselskab based in Karlslunde, founded in 2017. The company is registered under the industry Public relations og kommunikation. The management consists of Vibeke Wærens. The company is owned by VIPinvest ApS. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK 2,432,365 and a net result of DKK 674,851 compared with DKK 1,191,483 the year before. Equity in the 2025 report amounted to DKK 1,263,395.